These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24402667)

  • 1. [Phosphate control in end stage renal disease: barriers and opportunities. Malnutrition: yes or not?].
    Di Iorio B; Di Micco L
    G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate control in end-stage renal disease: barriers and opportunities.
    Waheed AA; Pedraza F; Lenz O; Isakova T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2961-8. PubMed ID: 23901051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate homeostasis and the renal-gastrointestinal axis.
    Marks J; Debnam ES; Unwin RJ
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F285-96. PubMed ID: 20534868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label use of phosphate binders in non-dialysis-dependent CKD.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2010 Nov; 56(5):813-6. PubMed ID: 20970022
    [No Abstract]   [Full Text] [Related]  

  • 6. [The contribution of dialysis and laboratoristic methods for the control of phosphates].
    Bolasco P
    G Ital Nefrol; 2014; 31(2):. PubMed ID: 24777923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate: a stealthier killer than previously thought?
    Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
    Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for hyperphosphatemia in feline CKD: what's out there?
    Kidder AC; Chew D
    J Feline Med Surg; 2009 Nov; 11(11):913-24. PubMed ID: 19857854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate binders. Is selection determined by price?: Yes.
    de Francisco AL
    Nefrologia; 2012; 32(2):235-9. PubMed ID: 22466264
    [No Abstract]   [Full Text] [Related]  

  • 11. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic renal failure: what is the optimal diet?].
    Lu Y; Vakilzadeh N; Teta D
    Praxis (Bern 1994); 2015 Mar; 104(7):361-7. PubMed ID: 25804779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate control in chronic uremia: don't forget diet.
    Cupisti A; Morelli E; D'Alessandro C; Lupetti S; Barsotti G
    J Nephrol; 2003; 16(1):29-33. PubMed ID: 12649532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
    Wald R; Rabbat CG; Girard L; Garg AX; Tennankore K; Tyrwhitt J; Smyth A; Rathe-Skafel A; Gao P; Mazzetti A; Bosch J; Yan AT; Parfrey P; Manns BJ; Walsh M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):965-973. PubMed ID: 28550080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
    Sullivan C; Sayre SS; Leon JB; Machekano R; Love TE; Porter D; Marbury M; Sehgal AR
    JAMA; 2009 Feb; 301(6):629-35. PubMed ID: 19211470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nutritional management of patients suffering of chronic renal failure].
    Rondanelli M; Opizzi A; Bonisio A; Lingua S; Cena H; Giacosa A; Roggi C
    Minerva Urol Nefrol; 2005 Mar; 57(1):33-45. PubMed ID: 15944520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate Binders and Targets Over Decades: Do We have it Right Now?
    Marcuccilli M; Chonchol M; Jovanovich A
    Semin Dial; 2017 Mar; 30(2):134-141. PubMed ID: 28064444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary glands: a new player in phosphorus metabolism.
    Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
    J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
    Pavlović D; Katicić D; Josipović J
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wakame (Undaria pinnatifida ) modulates hyperphosphatemia in a rat model of chronic renal failure.
    Katai K; Iwamoto A; Kimura Y; Oshima Y; Arioka S; Morimi Y; Omuro A; Nakasa T
    J Med Invest; 2015; 62(1-2):68-74. PubMed ID: 25817287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.